S. A. Santos

发表

Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of action.

A. Paulo, S. A. Santos, 2013, Current cancer drug targets.

Bis-alkylamine quindolone derivatives as new antimalarial leads.

J. Gut, P. Rosenthal, J. Lavrado, 2010, Bioorganic & medicinal chemistry letters.

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs

S. Lindquist, G. Estiu, O. Wiest, 2015, Science Translational Medicine.

The Cytoplasmic Prolyl-tRNA Synthetase of the Malaria Parasite is a Dual-Stage Target for Drug Development

S. Lindquist, G. Estiu, O. Wiest, 2015 .

Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype.

D. Wirth, Ralph Mazitschek, R. Moreira, 2015, European journal of medicinal chemistry.

N10,N11-di-alkylamine indolo[3,2-b]quinolines as hemozoin inhibitors: design, synthesis and antiplasmodial activity.

J. Gut, P. Rosenthal, T. Egan, 2015, Bioorganic & medicinal chemistry.

Bis-alkylamine Indolo[3,2-b]quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activities.

J. Gut, P. Rosenthal, J. Lavrado, 2014, Journal of medicinal chemistry.

Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives

Stephan A. Ohnmacht, S. Neidle, J. Lavrado, 2015, PloS one.

The Adaptive Proline Response in P. falciparum Is Independent of PfeIK1 and eIF2α Signaling.

D. Wirth, C. Clish, Ralph Mazitschek, 2019, ACS infectious diseases.

Exploring the 3-piperidin-4-yl-1H-indole scaffold as a novel antimalarial chemotype.

D. Wirth, Ralph Mazitschek, R. Moreira, 2015, European journal of medicinal chemistry.